MarginsXMarginsX
Home › Markets › AAVXF

Abivax S.A. (AAVXF)

AAVXF is quoted over the counter, not listed on an exchange. Abivax S.A. files reports with the SEC; the numbers below come from SEC filings and from daily closes, each with its source.

Last trade · November 5, 2026
$84.80
No trades since Nov 5, 2026; later closes repeat the last quote
1-year return
-19.2%
Market cap
The company also trades on Nasdaq as ABVX; this OTC line is another class or a foreign line, so its cap is not computed
P/E and P/S
Needs a market cap · Needs a market cap
On fiscal year to December 31, 2025 (20-F)

Closes: Yahoo Finance daily closes, last bar 2026-11-13.

Profile

FieldValue
TickerAAVXF, quoted over the counter
SEC CIK0001956827
OTC Markets tierPink (price source, 2026-11-13)
SEC industry codePharmaceutical Preparations
Business addressParis
Incorporated inFrance

Warning signs

Cash runway
38.5 months
516.7M EUR cash at December 31, 2025
Share count, 1 year
+24.0%
2024-12-31 to 2025-12-31
Going-concern doubt
No
20-F filed March 23, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.20-F 2026-03-23
Cash and burn516.7M EUR cash; operating cash flow -40.3M EUR a quarter.Report 2025-12-31
Shares outstanding78,536,412 (2025-12-31); 63,347,837 a year earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures.Cover page 2025-12-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-07-02
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPRICEWATERHOUSECOOPERS AUDIT, NEUILLY-SUR-SEINE, FrancePCAOB Form AP 2026-04-24
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
Not filed-336.1M EUR-161.1M EUR516.7M EURNo debt tagsNeeds four quarters20-F 2026-03-23
FY 2024
2024-12-31
Not filed-176.2M EUR-154.1M EUR144.2M EURNo debt tagsNeeds four quarters20-F 2026-03-23
FY 2023
2023-12-31
Not filed-147.7M EUR-97.1M EUR251.9M EURNo debt tagsNeeds four quarters20-F 2026-03-23
FY 2022
2022-12-31
Not filed-60.7M EUR-53.9M EUR26.9M EURNo debt tagsNeeds four quarters20-F 2025-03-24
FY 2021
2021-12-31
Not filed-42.5M EUR-45.0M EUR60.7M EURNo debt tagsNeeds four quarters20-F 2024-04-05

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-07-02
Latest annual report20-F2026-03-23
Latest quarterly / interim6-K2026-09-21

Source: SEC EDGAR submissions feed, 106 recent filings. All filings on EDGAR.

The full dossier has every filing, quarterly and annual financials, the health record and a price chart.

Open the full dossier